Actio launches dedicated patient resource to support families seeking information about the KYRON clinical trial at ...

Asset Value Investors Limited (“AVI”) today announced an update to its public campaign regarding Rohto Pharmaceutical Co., Ltd. (TSE: 4527, “Rohto”), as a follow-up to its ongoing campaign, “Awakening ...

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to delay the launch of the ...

Veteran trial lawyer honored on 2026 list for excellence in mass tortsDALLAS--(BUSINESS WIRE)--Ben C. Martin, founding partner of the elite personal injury law firm Ben Martin Law Group, has been ...

As part of the 10th annual awards program, Welldoc recognized for continued AI leadership and innovation across cardiometabolic healthCOLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, an AI-powered health ...

Landmark 10th Annual Awards Program Recognizes the Deseyne® Extended Depth of Focus (EDOF) contact lens as the “Best New ...

U.S. net sales of $273 million in Q1 2026, primarily driven by improved net price and 5% EUTRx demand growth year-over-year – ...

In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...

VANCOUVER, BC / ACCESS Newswire / May 8, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that Nucro-Technics Inc.

Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions WorldwideBOSTON--(BUSINESS WIRE)--#arterialplaque--Elucid, an AI medical technology ...

AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:Bank of America ...

"As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, ...